| Title |
Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents
|
|---|---|
| Published in |
Cochrane database of systematic reviews, July 2012
|
| DOI | 10.1002/14651858.cd007986.pub2 |
| Pubmed ID | |
| Authors | |
| Abstract |
Attention deficit hyperactivity disorder (ADHD) is a major problem in children and adolescents, characterised by age-inappropriate levels of inattention, hyperactivity and impulsivity, and is associated with long-term social, academic and mental health problems. The stimulant medications methylphenidate and amphetamine are the most frequently used treatments for ADHD, but these are not always effective and can be associated with side effects. Clinical and biochemical evidence suggests that deficiencies of polyunsaturated fatty acids (PUFA) could be related to ADHD. Children and adolescents with ADHD have been shown to have significantly lower plasma and blood concentrations of PUFA and, in particular, lower levels of omega-3 PUFA. These findings suggest that PUFA supplementation may reduce the attention and behaviour problems associated with ADHD. |
Login to access the Attention Digest and the Sentiment Analysis related to this output.
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 3 | 14% |
| Australia | 3 | 14% |
| Netherlands | 2 | 10% |
| United Kingdom | 2 | 10% |
| United States | 2 | 10% |
| Spain | 1 | 5% |
| Germany | 1 | 5% |
| Canada | 1 | 5% |
| Unknown | 6 | 29% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 17 | 81% |
| Practitioners (doctors, other healthcare professionals) | 2 | 10% |
| Scientists | 2 | 10% |